Table 4.
2001–2003 (n=169) | 2007–2009 (n=482) | P value* | |
---|---|---|---|
Inflammation or bowel wall thickening | 65(38.5%) | 257 (53.3%) | .003 |
| |||
Obstruction | 35 (20.7%) | 95 (19.7%) | .90 |
| |||
Abscess or perforation | 17 (10.1%) | 50 (10.4%) | .12 |
| |||
Fistula | |||
Perianal | 4 (2.4%) | 9 (1.9%) | .36 |
Other | 17 (10.1%) | 29 (6.0%) | .20 |
| |||
Non-CD urgent/emergent diagnoses | 11 (6.5%) | 34 (7.0%) | .99 |
| |||
POA | 51 (30.2%) | 138(28.6%) | .92 |
| |||
POANCD | 61 (36.1%) | 166 (34.4%) | .91 |
Multivariable model adjusted for differences in aminosalicylate and biologic medication use